Literature DB >> 15582982

Mammalian defensins: structures and mechanism of antibiotic activity.

Hans-Georg Sahl1, Ulrike Pag, Sonja Bonness, Sandra Wagner, Nikolinka Antcheva, Alessandro Tossi.   

Abstract

Antibiotic peptides are important effector molecules in host-parasite interactions throughout the living world. In vertebrates, they function in first-line host defense by antagonizing a wide range of microbes including bacteria, fungi, and enveloped viruses. The antibiotic activity is thought to be based on their cationic, amphipathic nature, which enables the peptides to impair vital membrane functions. Molecular details for such activities have been elaborated with model membranes; however, there is increasing evidence that these models may not reflect the complex processes involved in the killing of microbes. For example, the overall killing activity of the bacterial peptide antibiotic nisin is composed of independent activities such as the formation of target-mediated pores, inhibition of cell-wall biosynthesis, formation of nontargeted pores, and induction of autolysis. We studied the molecular modes of action of human defense peptides and tried to determine whether they impair membrane functions primarily and whether additional antibiotic activities may be found. We compared killing kinetics, solute efflux kinetics, membrane-depolarization assays, and macromolecular biosynthesis assays and used several strains of Gram-positive cocci as test strains. We found that membrane depolarization contributes to rapid killing of a significant fraction of target cells within a bacterial culture. However, substantial subpopulations appear to survive the primary effects on the membrane. Depending on individual strains and species and peptide concentrations, such subpopulations may resume growth or be killed through additional activities of the peptides. Such activities can include the activation of cell-wall lytic enzymes, which appears of particular importance for killing of staphylococcal strains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582982     DOI: 10.1189/jlb.0804452

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  55 in total

1.  Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl.

Authors:  Yair Goldfeder; Fadia Zaknoon; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

2.  The beta-defensin gallinacin-6 is expressed in the chicken digestive tract and has antimicrobial activity against food-borne pathogens.

Authors:  Albert van Dijk; Edwin J A Veldhuizen; Stefanie I C Kalkhove; Johanna L M Tjeerdsma-van Bokhoven; Roland A Romijn; Henk P Haagsman
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

3.  Bilayer lipid composition modulates the activity of dermaseptins, polycationic antimicrobial peptides.

Authors:  Hervé Duclohier
Journal:  Eur Biophys J       Date:  2006-02-14       Impact factor: 1.733

4.  Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.

Authors:  Viswanatha Krishnakumari; Nandini Rangaraj; Ramakrishnan Nagaraj
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

5.  Insights into the mode of action of chitosan as an antibacterial compound.

Authors:  Dina Raafat; Kristine von Bargen; Albert Haas; Hans-Georg Sahl
Journal:  Appl Environ Microbiol       Date:  2008-05-02       Impact factor: 4.792

6.  Immunology: Peptide gets in shape for self-defence.

Authors:  Robert I Lehrer
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

Review 7.  Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action.

Authors:  Maria Luisa Mangoni; Yechiel Shai
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

8.  Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci.

Authors:  Vera Sass; Tanja Schneider; Miriam Wilmes; Christian Körner; Alessandro Tossi; Natalia Novikova; Olga Shamova; Hans-Georg Sahl
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

Review 9.  Diversity in penaeidin antimicrobial peptide form and function.

Authors:  Brandon J Cuthbertson; Leesa J Deterding; Jason G Williams; Kenneth B Tomer; Kizee Etienne; Perry J Blackshear; Erika E Büllesbach; Paul S Gross
Journal:  Dev Comp Immunol       Date:  2007-08-03       Impact factor: 3.636

10.  Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines.

Authors:  Olga Scudiero; Stefania Galdiero; Ersilia Nigro; Luigi Del Vecchio; Rosa Di Noto; Marco Cantisani; Irene Colavita; Massimiliano Galdiero; Jean-Jacques Cassiman; Aurora Daniele; Carlo Pedone; Francesco Salvatore
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.